The United States Patent and Trademark Office (USPTO) has submitted a “Notice of Allowance” regarding patent application 13/522,741 and thereby intends to approve Immunicum’s patent to protect the way to activate the Company’s cancer vaccine cells in the US market.
Read the press release here: Press release 141215 – Approved US-patent
Notice: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4805